The triple win – implementation science benefits patients, healthcare systems and industry alike-Reference-Cited by-同舟云学术

The triple win – implementation science benefits patients, healthcare systems and industry alike

Published:2022-06 Issue:9 Volume:11 Page:639-642
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:J. Comp. Eff. Res.

Author:

Olson Melvin (Skip)¹^ORCID,Rootkin Linda²^ORCID

Affiliation:

1. Global Head of Integrated Evidence Strategy and Innovation, Global Medical Affairs, Novartis Pharma AG, Basel, Switzerland

2. Head, Strategic Partnerships & Implementation Science, Latin America & Canada, Novartis Latin America Services, Inc, Miami, FL 33126, USA

Publisher

Becaris Publishing Limited

Subject

Health Policy

Link

https://becarispublishing.com/doi/pdf/10.2217/cer-2022-0058

Reference15 articles.

1. Managing clinical knowledge for health care improvement;Balas EA;Yearb. Med. Inform.,2000

2. From appropriate care to evidence-based medicine;Balas EA;Pediatr. Ann.,1998

3. Powering Swiss health care for the future: implementation science to bridge “the valley of death”;De Geest S;Swiss. Med. Wkly.,2020

4. The quality of health care delivered to adults in the United States;Mcglynn EA;N. Engl. J. Med.,2003

5. Medizinischer Fortschritt: Warum verläuft die Translation biologischer Erkenntnisse in neue Therapien so schleppend?;Scheidegger D;SAMW Bulletin,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How pharma can amplify product value with implementation science;Journal of Comparative Effectiveness Research;2024-09-06

2. Moving from research to clinical care: Building therapist capacity to deliver the teen online problem-solving program for acquired brain injuries in adolescence.;Rehabilitation Psychology;2024-08

3. The value of evidence and its role in driving product strategy;Journal of Comparative Effectiveness Research;2024-08

4. Redefining the Role of Medical Affairs Professionals as Innovators and Leaders in Industry-Led Medical Education;Pharmaceutical Medicine;2024-04-15

5. The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE);Drug Safety;2024-03-13